INGR up +0.71% percent right now. $INGR High is at 80.71

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
INGR up +0.71% percent right now. $INGR High is at 80.71 and the Low 79.74 with current volume of 147,349.

Recent News posted below.

INGR Ingredion Inc Recent Headline News

INGREDION TO WEBCAST PRESENTATION TO ANALYSTS ON NOVEMBER 18, 2014
Thomson Reuters ONE - Thu Nov 06, 12:29PM CST
WESTCHESTER, Ill., Nov. 6, 2014 - Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to diversified industries, will webcast its Analyst Day presentation on Tuesday, November 18, 2014. Ingredion's senior executives will present a business overview, including a review of future growth drivers, financial performance and long-term targets for the Company.
INGR: 80.39 (+0.55)

5 Takeaways From Ingredion's Quarterly Statement
William Bias - at Seeking Alpha - Thu Nov 06, 8:07AM CST

INGR: 80.39 (+0.55)

Ingredion: A Safe Haven With Improving Prospects
Darspal S Mann - at Seeking Alpha - Wed Nov 05, 9:11AM CST

INGR: 80.39 (+0.55)

INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board of Directors of Penford Corporation Regarding the Fairness of the Sale of the Company to Ingredion Incorporated - PENX
PR Newswire - Tue Nov 04, 11:04AM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Penford Corporation (NasdaqGM: PENX) ("Penford" in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 80.39 (+0.55), PENX: 18.83 (+0.07)

Ingredion Incorporated's (INGR) CEO Ilene Gordon on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 5:40PM CDT

INGR: 80.39 (+0.55)

Ingredion meets 3Q profit forecasts
Automated Insights - Thu Oct 30, 10:24AM CDT
WESTCHESTER, Ill. (AP) _ Ingredion Inc. (INGR) on Thursday reported third-quarter net income of $118.6 million.
INGR: 80.39 (+0.55)

Ingredion beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 8:20AM CDT

INGR: 80.39 (+0.55)

INGREDION INCORPORATED REPORTS SOLID THIRD QUARTER 2014 RESULTS
Thomson Reuters ONE - Thu Oct 30, 5:30AM CDT
- Third quarter 2014 EPS rose 45 percent to $1.60 from $1.10 in the third quarter 2013
INGR: 80.39 (+0.55)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:30PM CDT

FIS: 58.50 (+0.12), HST: 22.77 (+0.11), CRR: 50.30 (-0.90), CAH: 78.99 (+0.72), AMT: 99.31 (-0.16), ACIW: 18.51 (-0.01), GTI: 4.34 (-0.15), IDA: 63.01 (+0.46), CRCM: 8.45 (-0.11), CVRR: 23.07 (-0.74), BGCP: 8.51 (+0.03), GOV: 23.32 (+0.14), DFT: 31.00 (+0.41), APO: 23.46 (+0.08), FIG: 7.32 (unch), AMAG: 34.86 (-0.09), HAR: 107.48 (+0.40), AVP: 10.45 (-0.13), EXLS: 28.81 (+0.12), INGR: 80.39 (+0.55), ALU: 3.16 (-0.16), INCY: 70.93 (+1.61), COP: 71.61 (-0.55), GEL: 49.38 (-0.21), COR: 37.89 (+0.09), GTLS: 45.84 (-1.11), BWA: 56.32 (-1.36), CARB: 10.95 (-0.10), GLOP: 26.13 (-0.03), IDCC: 49.55 (-0.03), HEES: 38.66 (+0.29), BCO: 21.34 (-0.17), DST: 99.27 (+0.08), EPD: 37.71 (+0.09), ABMD: 32.93 (+0.80), CEVA: 15.75 (-0.05), BLL: 65.75 (+0.78), GBX: 61.26 (+1.35), GNC: 43.02 (-0.04), CVI: 47.55 (-1.36), ACOR: 36.17 (+1.06), I: 18.23 (-0.38), FCN: 40.90 (+0.17), CRNT: 1.15 (-0.02), DHX: 10.89 (+0.36), BG: 88.85 (+0.09), CME: 85.78 (+0.18), FCH: 10.67 (-0.11), ALLE: 52.65 (-0.31), AUDC: 4.87 (-0.10), APD: 134.85 (-0.09), DBD: 35.97 (-0.09), HGG: 5.43 (-0.10), CBM: 23.00 (+0.34), CNSL: 26.08 (+0.08), ATK: 109.93 (+1.10), ANR: 2.63 (-0.28), CI: 101.24 (+2.25), ABC: 87.64 (+0.91), GG: 19.09 (-0.93)

PENFORD CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Business Wire - Tue Oct 28, 10:55AM CDT
Rigrodsky & Long, P.A.:
INGR: 80.39 (+0.55), PENX: 18.83 (+0.07)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Penford Corporation of Class Action Against the Board of Directors of the Company Regarding the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
GlobeNewswire - Tue Oct 28, 10:29AM CDT
Levi & Korsinsky notifies investors of Penford Corporation ("Penford" or "the Company" (NasdaqENX) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Ingredion Incorporated (NYSE:INGR). A complaint was filed in Colorado federal court.
INGR: 80.39 (+0.55), PENX: 18.83 (+0.07)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Penford Corporation Regarding the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
Business Wire - Mon Oct 27, 10:01AM CDT
Levi & Korsinsky is investigating the Board of Directors of Penford Corporation ("Penford" or "the Company" (NasdaqGM: PENX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 80.39 (+0.55), PENX: 18.83 (+0.07)

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Penford Corporation Concerning the Fairness of the Sale of the Company to Ingredion Incorporated -- PENX
PR Newswire - Mon Oct 20, 10:05AM CDT
Levi & Korsinsky is investigating the Board of Directors of Penford Corporation ("Penford" or "the Company" (NasdaqGM: PENX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Ingredion Incorporated (NYSE: INGR).
INGR: 80.39 (+0.55), PENX: 18.83 (+0.07)

Assessing Risk In Equities In The Consumer Staple Sector
Factoids - at Seeking Alpha - Mon Oct 20, 3:04AM CDT

KO: 42.34 (+0.02), MKC: 72.93 (+0.17), CLX: 101.38 (+0.59), CAG: 34.46 (-0.16), HSY: 96.45 (+0.02), INGR: 80.39 (+0.55), KMB: 113.77 (+0.53), HRL: 54.37 (-0.05), SJM: 105.04 (+0.20), PEP: 96.85 (+0.05), K: 63.84 (+0.18), ADM: 50.68 (+0.13), CPB: 44.24 (+0.14), LANC: 91.43 (+0.73), PG: 89.37 (+0.24), FLO: 19.63 (+0.28), GIS: 50.82 (-0.54), CL: 68.44 (+0.39)

Dividend Challengers (And Near-Challengers): 57 Increases Expected By New Year's Day
David Fish - at Seeking Alpha - Sat Oct 18, 5:51PM CDT

RKT: 55.99 (+0.56), TTC: 62.86 (-0.10), HST: 22.77 (+0.11), OCR: 68.80 (+0.83), HI: 34.28 (+0.30), MAIN: 32.20 (-0.07), MHLD: 12.50 (unch), PRU: 86.49 (+1.16), DEI: 28.49 (+0.09), PSA: 187.89 (+1.60), THG: 69.19 (+0.04), KKR: 21.90 (+0.51), RL: 171.68 (-2.32), VTR: 68.59 (+0.33), AEP: 58.38 (+0.06), EVR: 51.57 (+0.94), TECH: 90.92 (+0.21), ROK: 112.54 (+0.25), INGR: 80.39 (+0.55), WTI: 8.92 (-0.39), COR: 37.89 (+0.09), EXL: 12.97 (+0.12), UG: 19.00 (-1.09), BGS: 29.41 (+0.16), ESV: 39.79 (-1.52), APTS: 8.70 (+0.04), EL: 72.84 (+0.26), HEI: 54.23 (+0.76), GE: 26.46 (+0.05), BOKF: 68.66 (+0.38), SNA: 135.54 (+0.42), BCPC: 64.99 (+1.00), SBUX: 77.69 (-0.10), V: 249.88 (-2.55), KIM: 24.92 (+0.13), BBSI: 24.16 (-1.07), SIX: 39.84 (-0.21), EMCI: 32.78 (+0.93), CHS: 14.99 (-0.16), NEU: 390.00 (+1.46), BMR: 21.65 (+0.21), EMN: 83.64 (+1.17), PRA: 45.05 (-0.18), CBL: 19.40 (+0.42), CUBE: 21.01 (+0.04), DIS: 89.61 (-0.39), BMY: 58.69 (+0.37), ABC: 87.64 (+0.91), RCII: 31.60 (+0.18), WCN: 50.34 (+0.63), HCI: 43.85 (+0.74), MAC: 69.48 (+1.00), AMTD: 35.01 (+0.42), HUB.B: 111.75 (+0.25), JCI: 49.14 (+0.38)

PENFORD CORPORATION INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penford Corporation
PR Newswire - Wed Oct 15, 5:28PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF" are investigating the proposed sale of Penford Corporation ("Penford" or the "Company" (NASDAQ: PENX) to Ingredion Incorporated (NYSE: INGR). Under the terms of the proposed transaction, shareholders of Penford will receive only $19 in cash for each share of Penford common stock that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
INGR: 80.39 (+0.55), PENX: 18.83 (+0.07)

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Penford Corporation Stockholders
Business Wire - Wed Oct 15, 4:52PM CDT
Kirby McInerney LLP is investigating potential claims against Penford Corporation ("Penford" or the "Company" (NASDAQ: PENX) concerning the proposed acquisition of the Company by Ingredion Incorporated ("Ingredion" (NYSE: INGR). Under the terms of the definitive merger agreement, Penford stockholders will receive $19.00 in cash for each share of Penford common stock they own, valuing the transaction at approximately $340 million.
INGR: 80.39 (+0.55), PENX: 18.83 (+0.07)

Ingredion: Nice Deal, Nice Appeal!
The Value Investor - at Seeking Alpha - Wed Oct 15, 3:08PM CDT

INGR: 80.39 (+0.55), PENX: 18.83 (+0.07)

Penford agrees to sale in $340M deal
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 2:38PM CDT

INGR: 80.39 (+0.55), PENX: 18.83 (+0.07)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 158

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Jeff McLean Takes the Helm as ghSMART's New CEO

Updated Category News Views 620

Jeff McLean Takes the Helm as ghSMART's New CEO G.H. Smart & Company, LLC, the leading firm in leadership advisory, proudly announces the appointment of Jeff McLean as the Chief Executive Officer. McLean, who has been serving as President of ghSMART for three years, will now guide the firm towards its next exciting phase of growth and innovation. Achievements Under...

Continue Reading
Growth Forecast for Hot Dog and Sausage Market to 2032

Updated Category News Views 51

Introduction to the Hot Dog and Sausage Market The global market for hot dogs and sausages is witnessing a remarkable upward trajectory, with projections estimating it will reach USD 112.41 billion by 2032. This growth is fueled by a compound annual growth rate (CAGR) of 3.50%. The factors contributing to this expansion are numerous, including shifting consumer...

Continue Reading
Exro Technologies Adjusts Leadership with New CEO Plans

Updated Category News Views 337

Exro Technologies Announces Leadership Changes Exro Technologies Inc. has made a significant announcement regarding its leadership structure. Following the resignation of Sue Ozdemir from her role as Chief Executive Officer, the company has initiated steps to ensure a seamless transition and continuity in leadership. New Chief Restructuring Officer Appointed Introduction...

Continue Reading
Hillenbrand Increases Quarterly Dividend to $0.225 Per Share

Updated Category News Views 208

Hillenbrand's Exciting Dividend Announcement The board of directors of Hillenbrand, Inc. (NYSE: HI) has proudly announced a regular cash dividend of $0.225 per share on its common stock. This announcement signifies an annual increase of $0.01, bringing the total dividend rate to $0.90 per share for fiscal 2025. Such a commitment underlines Hillenbrand's dedication to...

Continue Reading
Trump's World Liberty Financial Token Sale Raises $220 Million

Updated Category News Views 113

Trump's World Liberty Financial Token Sale Demonstrates Huge Demand The World Liberty Financial project, closely associated with Donald Trump, made headlines recently as its token sale reached an impressive $220 million in just the first hour. Despite facing multiple outages on its website, the initiative showcased remarkable demand and interest. Details of the Token Sale...

Continue Reading